List of Excipients in API olopatadine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olopatadine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | PATANOL | olopatadine hydrochloride | 0065-0271 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | PATANOL | olopatadine hydrochloride | 0065-0271 | HYDROCHLORIC ACID | |
| Alcon Laboratories Inc | PATANOL | olopatadine hydrochloride | 0065-0271 | SODIUM CHLORIDE | |
| Alcon Laboratories Inc | PATANOL | olopatadine hydrochloride | 0065-0271 | SODIUM HYDROXIDE | |
| Alcon Laboratories Inc | PATANOL | olopatadine hydrochloride | 0065-0271 | SODIUM PHOSPHATE, DIBASIC | |
| Alcon Laboratories Inc | PATANOL | olopatadine hydrochloride | 0065-0271 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing olopatadine hydrochloride
Detailed excipient profiles for olopatadine hydrochloride
Excipient focus: BENZALKONIUM CHLORIDE
olopatadine hydrochloride drug variants containing BENZALKONIUM CHLORIDE
olopatadine hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
olopatadine hydrochloride drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-0816 |
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-4273 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing BORIC ACID
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
olopatadine hydrochloride drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olopatadine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: EDETATE DISODIUM
olopatadine hydrochloride drug variants containing EDETATE DISODIUM
olopatadine hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
olopatadine hydrochloride drug variants containing HYDROCHLORIC ACID
olopatadine hydrochloride drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olopatadine hydrochloride | 0093-7684 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN
olopatadine hydrochloride drug variants containing HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-0816 |
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-4273 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN
Excipient focus: HYPROMELLOSE
olopatadine hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-0816 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
olopatadine hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-4273 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: MANNITOL
olopatadine hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-0816 |
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-4273 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing MANNITOL
Excipient focus: POLYETHYLENE GLYCOL 400
olopatadine hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-0816 |
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-4273 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYSORBATE 80
olopatadine hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
olopatadine hydrochloride drug variants containing POVIDONE
olopatadine hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
olopatadine hydrochloride drug variants containing POVIDONE K30
olopatadine hydrochloride drug variants not containing POVIDONE K30
Excipient focus: SODIUM CHLORIDE
olopatadine hydrochloride drug variants containing SODIUM CHLORIDE
olopatadine hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-0816 |
| Alcon Laboratories Inc | olopatadine hydrochloride | 0065-4273 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
olopatadine hydrochloride drug variants containing SODIUM HYDROXIDE
olopatadine hydrochloride drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olopatadine hydrochloride | 0093-7684 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allegiant Health | olopatadine hydrochloride | 69168-480 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | olopatadine hydrochloride usp, 0.1% | 64980-517 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ECI Pharmaceuticals LLC | olopatadine hydrochloride | 51293-838 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
olopatadine hydrochloride drug variants containing SODIUM PHOSPHATE, MONOBASIC
olopatadine hydrochloride drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: WATER
olopatadine hydrochloride drug variants containing WATER
olopatadine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | olopatadine hydrochloride ophthalmic solution | 69097-276 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links